Sign up
Quantellect · Analysts · Analyst Profile
Q Score Rank#25 of 388

Chase Knickerbocker

Craig-Hallum · Equity Research Analyst
ProvisionalRating since 2022No new ratings since Jul 2025

Analyst rating accuracy & track record

Chase Knickerbocker is an equity research analyst at Craig-Hallum. Quantellect has scored 33 of their stock calls across 14 companies. Their picks beat their sector 58% of the time over the next 12 months, and their price targets were reached 45% of the time within a year.

Win % vs sector
58%
PT Hit % (12mo)
45%
Avg sector-excess
+7.1%
Scored calls
33
Tickers
14
Tier
Provisional

Track record

Quantellect has scored 33 of Chase Knickerbocker's stock calls across 14 companies, dating back to 2022. Their rated stocks beat their own sector 58% of the time over the next 12 months. On a typical call, a Knickerbocker pick returned +7.1% more than its sector over the following year.

Of the scored calls, 33 were bullish (Buy). Most of their coverage sits in Unknown. Every number on this page is an estimate from our own data. It is for education only and is not investment advice.

Coverage & ratings

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
DMACDiaMedica Therapeutics Inc
Buy$11.00Jul 2025+31.3%Miss
INDVIndivior PLC Ordinary Shares
Buy$22.00Jun 2025+162.3%Hit
NRXSNeuraxis, Inc.
Buy$7.00Jun 2025+138.5%Hit
PHATPhathom Pharmaceuticals Inc
Buy$17.00Jun 2025−6.5%Hit
ETONEton Pharmaceuticals Inc
Buy$28.00May 2025+38.9%Hit
FENCFennec Pharmaceuticals Inc
Buy$13.00May 2025+27.9%Miss
ETONEton Pharmaceuticals Inc
Buy$26.00Mar 2025+39.0%Miss
XERSXeris Pharmaceuticals Inc
Buy$6.50Mar 2025+15.7%Hit
MDWDMediwound Ltd
Buy$39.00Feb 2025−5.5%Miss
IRWDIronwood Pharmaceuticals Inc
Buy$8.00Jan 2025+31.2%Miss
DCTHDelcath Systems Inc
Buy$21.00Jan 2025−42.9%Miss
KRMDRepro Med Systems Inc
Buy$6.00Jan 2025+23.8%Hit
ETONEton Pharmaceuticals Inc
Buy$18.00Jan 2025+7.7%Hit
KRMDRepro Med Systems Inc
Buy$5.00Nov 2024+27.3%Hit
PYPDPolyPid
Buy$10.00Nov 2024+15.1%Miss
ETONEton Pharmaceuticals Inc
Buy$15.00Oct 2024+118.0%Hit
INDVIndivior PLC Ordinary Shares
Buy$16.00Oct 2024+208.8%Hit
ETONEton Pharmaceuticals Inc
Buy$10.00Oct 2024+186.8%Hit
FENCFennec Pharmaceuticals Inc
Buy$15.00Aug 2024+63.7%Miss
IRWDIronwood Pharmaceuticals Inc
Buy$10.00Aug 2024−69.0%Miss
MDXGMiMedx Group Inc
Buy$12.00Aug 2024+22.4%Miss
INDVIndivior PLC Ordinary Shares
Buy$24.00Jul 2024+41.6%Miss
DCTHDelcath Systems Inc
Buy$18.00Jun 2024+70.1%Hit
FENCFennec Pharmaceuticals Inc
Buy$17.00May 2024+1.2%Miss
IRWDIronwood Pharmaceuticals Inc
Buy$14.00May 2024−85.3%Miss
ETONEton Pharmaceuticals Inc
Buy$8.00May 2024+351.3%Hit
INDVIndivior PLC Ordinary Shares
Buy$37.00Apr 2024−58.7%Miss
FENCFennec Pharmaceuticals Inc
Buy$18.00Mar 2024−42.3%Miss
IRWDIronwood Pharmaceuticals Inc
Buy$21.00Jan 2024−71.8%Miss
MDXGMiMedx Group Inc
Buy$12.00Oct 2023−29.4%Miss
XTNTXtant Medical Holdings Inc
Buy$1.20Jul 2023−44.5%Hit
XTNTXtant Medical Holdings Inc
Buy$1.00Apr 2023+14.6%Hit
FENCFennec Pharmaceuticals Inc
Buy$14.00Aug 2022+17.4%Miss
Go to

Chase Knickerbocker: analyst track record FAQ

Is Chase Knickerbocker a good stock analyst?

Yes, by track record. Chase Knickerbocker ranks number 25 of 388 of the analysts Quantellect scores, with a Q Score of 71 out of 100. Past results do not guarantee future ones.

What is Chase Knickerbocker's win rate?

Chase Knickerbocker's win rate is 58%. Across 33 scored calls, their rated stocks beat their sector 58% of the time over the next 12 months. On a typical call they returned +7.1% more than the sector.

What stocks and sectors does Chase Knickerbocker cover?

Chase Knickerbocker covers 14 companies, with the most coverage in Unknown. See the ratings table above for every scored call and its outcome.

Are Chase Knickerbocker's price targets accurate?

Chase Knickerbocker's price targets are reached within 12 months 45% of the time. The base rate across all analysts Quantellect tracks is about 43 percent.

How accurate are Wall Street analyst price targets?

Most analyst price targets are not reached on schedule. Across every target Quantellect scores, the stock reaches the target within 12 months only about 43 percent of the time, which is why it helps to compare hit rates analyst by analyst.

Should I follow Chase Knickerbocker's stock ratings?

Their track record is strong, but no analyst is right every time. Follow the long-term track record rather than any single rating, size your positions to your own risk, and treat this as research, not investment advice.

How does Quantellect score analyst accuracy?

Quantellect scores every rating on real prices. We enter at the closing price on or after the call date, with no look-ahead, then measure the 12-month return above the stock's sector ETF and check whether the price target was reached. Scores are pulled toward the population average and corrected for testing thousands of analysts at once, so they reflect repeatable skill rather than luck.

How does Chase Knickerbocker rank among Wall Street analysts?

Chase Knickerbocker ranks number 25 of 388 by Q Score. We rank analysts by their realized 12-month sector-excess return and require a minimum number of calls so a few lucky picks cannot reach the top.

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Quantellect calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.